 gsk aim stop aid profiteer one world largest manufacturer hivaids drug launched initiative combat smuggling cheaper pill supplied poorer african country back europe resale far higher price company glaxosmithkline alter packaging change colour pill currently provided developing nation humanitarian agreement estimated drug company losing hundred million dollar year result diversion product way sensitive area big drug company want maintain profit put tremendous pressure provide cheap antiaids drug world poorest nation result drug supplied africa thirty time cheaper sold europe bringing medicine within reach million hivpositive african government health care system wide difference price also mean big gain made illegally diverting cheaper drug back wealthier country reselling higher price glaxosmithkline belief coating pill destined africa red dye adding new identification code onto pill packaging trade substantially reduced company say possible identify specific distributor africa resold humanitarian drug profit well supplier europe also involved trade glaxo say distribution newlook drug already begun chemical content identical currently sold europe